GlassScriptPhysician profile
Ganesh Arun
NPI 1386264679
$6,928.72
in general payments reported to CMS, 2019-2025
40 companies · $2,373 in 2025
The $2,373 reported for 2025 was more than what 95% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $958 · 2024: $3,597 · 2025: $2,373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,928.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $838.18 | 2023-2025 | Farxiga, Airsupra, Brilinta |
| Amgen INC. | $836.79 | 2023-2025 | Repatha, Repatha |
| Lexicon Pharmaceuticals, INC. | $699.92 | 2023-2024 | Inpefa |
| Phathom Pharmaceuticals, INC. | $533.85 | 2024-2025 | Voquezna |
| Inari Medical, INC. | $389.49 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novo Nordisk INC | $361.86 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $273.38 | 2023-2025 | |
| Mylan Specialty L.P. | $180.57 | 2023-2024 | Yupelri |
| Corcept Therapeutics | $179.24 | 2024-2025 | Korlym |
| Merck Sharp & Dohme LLC | $175.45 | 2023-2025 | Verquvo |
| Stryker Corporation | $170.05 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $155.17 | 2025 | Hawkone |
| E.R. Squibb & Sons, L.L.C. | $155.13 | 2023-2025 | Eliquis, Camzyos |
| Lilly USA, LLC | $148.56 | 2023-2024 | Mounjaro |
| Pfizer INC. | $135.05 | 2023-2025 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $131.74 | 2023-2025 | Rexulti |
| Abbott Laboratories | $130.98 | 2023 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $128.63 | 2023-2025 | Jardiance |
| Madrigal Pharmaceuticals | $127.64 | 2025 | Rezdiffra |
| Janssen Pharmaceuticals, INC | $125.53 | 2024 | Xarelto |
| Exact Sciences Corporation | $117.14 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Abbvie INC. | $112.60 | 2023-2024 | Linzess, Creon, Viberzi |
| Bayer Healthcare Pharmaceuticals INC. | $111.92 | 2024-2025 | |
| Otsuka America Pharmaceutical, INC. | $107.88 | 2024 | Rexulti |
| Viatris Specialty LLC | $94.45 | 2025 | Yupelri |
| Smith+Nephew, INC. | $70.35 | 2025 | Renasys Go V2 Home, Collagenase Santyl, Allevyn Life L 15.4x15.4 Ctn10 |
| Glaxosmithkline, LLC. | $64.10 | 2025 | Trelegy Ellipta, Arexvy |
| Heartflow, INC. | $60.69 | 2025 | |
| Bridgebio Pharma, INC. | $50.99 | 2025 | Attruby |
| Boston Scientific Corporation | $39.11 | 2023-2024 | Watchman Access System |
| Daiichi Sankyo INC. | $34.17 | 2024 | Injectafer |
| Irhythm Technologies, INC. | $33.30 | 2024 | Zio Xt Patch, Zio Monitor |
| Cvrx, INC. | $28.97 | 2024 | Barostim Neo System |
| Sanofi-Aventis U.S. LLC | $25.47 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $19.20 | 2025 | Uptravi, Opsynvi |
| Tactile Systems Technology INC | $19.02 | 2025 | Flexitouch Plus, Nimbl |
| Acadia Pharmaceuticals INC | $16.74 | 2024 | Nuplazid |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.30 | 2025 | Xifaxan |
| Azurity Pharmaceuticals, INC. | $15.19 | 2024 | Edarbi |
| Kiniksa Pharmaceuticals International, Plc | $14.92 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ganesh Arun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.